Genome-wide histone acetylation profiling of Herpesvirus saimiri in human T cells upon induction with a histone deacetylase inhibitor

Journal of Virology

Volumn 85, Issue 11, 2011, Pages 5456-5464

  Alberter, Barbara ^a   Vogel, Benjamin ^a   Lengenfelder, Doris ^a   Full, Florian ^a   Ensser, Armin ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; TRICHOSTATIN A; VIRUS RNA;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; EPIGENETICS; EPISOME; EUCHROMATIN; GENE EXPRESSION REGULATION; GENE SILENCING; HERPES VIRUS INFECTION; HERPES VIRUS SAIMIRI; HETEROCHROMATIN; HISTONE ACETYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LATENT VIRUS INFECTION; LYMPHOCYTE TRANSFORMATION; NONHUMAN; ONCOGENE; ONCOGENE STPC; ONCOGENE TIP; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS GENOME; VIRUS REPLICATION; VIRUS STRAIN;

ACETYLATION; CELLS, CULTURED; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 2, SAIMIRIINE; HISTONE DEACETYLASE INHIBITORS; HISTONES; HOST-PATHOGEN INTERACTIONS; HUMANS; T-LYMPHOCYTES; VIRUS LATENCY;

HERPESVIRIDAE; SAIMIRIINE HERPESVIRUS 2;

EID: 79956144704     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00164-11     Document Type: Article

References (48)

1. Alberter, B., and A. Ensser. 2007. Histone modification pattern of the T-cellular Herpesvirus saimiri genome in latency. J. Virol. 81:2524-2530.
2. Amelio, A. L., N. V. Giordani, N. J. Kubat, J. E. O'Neil, and D. C. Bloom. 2006. Deacetylation of the herpes simplex virus type 1 latency-associated transcript (LAT) enhancer and a decrease in LAT abundance precede an increase in ICP0 transcriptional permissiveness at early times postexplant. J. Virol. 80:2063-2068.
3. Biesinger, B., et al. 1992. Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Proc. Natl. Acad. Sci. U. S. A. 89:3116-3119.
4. Calderwood, M. A., K. T. Hall, D. A. Matthews, and A. Whitehouse. 2004. The herpesvirus saimiri ORF73 gene product interacts with host-cell mitotic chromosomes and self-associates via its C terminus. J. Gen. Virol. 85:147-153.
5. Chau, C. M., and P. M. Lieberman. 2004. Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus. J. Virol. 78:12308-12319.
6. Chiba, T., et al. 2004. Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells. Oncology 66:481-491.
7. Collins, C. M., and P. G. Medveczky. 2002. Genetic requirements for the episomal maintenance of oncogenic herpesvirus genomes. Adv. Cancer Res. 84:155-174.
8. Dahlberg, J. E., D. V. Ablashi, J. S. Rhim, A. Fladger, and S. Z. Salahuddin. 1988. Replication of Herpesvirus saimiri is semipermissive in human cells because of a block in the synthesis of certain late proteins. Intervirology 29:227-234.
9. Deshmane, S. L., and N. W. Fraser. 1989. During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure. J. Virol. 63:943-947.
10. DeWire, S. M., and B. Damania. 2005. The latency-associated nuclear antigen of rhesus monkey rhadinovirus inhibits viral replication through repression of Orf50/Rta transcriptional activation. J. Virol. 79:3127-3138.
11. Ensser, A., et al. 2001. Independence of herpesvirus-induced T cell lymphoma from viral cyclin D homologue. J. Exp. Med. 193:637-642.
12. Ensser, A., A. Pfinder, I. Müller-Fleckenstein, and B. Fleckenstein. 1999. The URNA genes of herpesvirus saimiri (strain C488) are dispensable for transformation of human T cells in vitro. J. Virol. 73:10551-10555.
13. Ensser, A., M. Thurau, S. Wittmann, and H. Fickenscher. 2003. The genome of herpesvirus saimiri C488 which is capable of transforming human T cells. Virology 314:471-487.
14. Fickenscher, H., B. Biesinger, A. Knappe, S. Wittmann, and B. Fleckenstein. 1996. Regulation of the herpesvirus saimiri oncogene stpC, similar to that of T-cell activation genes, in growth-transformed human T lymphocytes. J. Virol. 70:6012-6019.
15. Fleckenstein, B., and R. C. Desrosiers. 1982. Herpesvirus saimiri and herpesvirus ateles, p. 253-332. In B. Roizman (ed.), The herpesviruses, vol. 1. Plenum Press, New York, NY.
16. Fowler, P., S. Marques, J. P. Simas, and S. Efstathiou. 2003. ORF73 of murine herpesvirus-68 is critical for the establishment and maintenance of latency. J. Gen. Virol. 84:3405-3416.
17. Gialitakis, M., et al. 2006. Coordinated changes of histone modifications and HDAC mobilization regulate the induction of MHC class II genes by trichostatin A. Nucleic Acids Res. 34:765-772.
18. Gradoville, L., D. Kwa, A. El Guindy, and G. Miller. 2002. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle. J. Virol. 76: 5612-5626.
19. Griffiths, R., S. M. Harrison, S. Macnab, and A. Whitehouse. 2008. Mapping the minimal regions within the ORF73 protein required for herpesvirus saimiri episomal persistence. J. Gen. Virol. 89:2843-2850.
20. Günther, T., and A. Grundhoff. 2010. The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog. 6:e1000935.
21. Heck, E., et al. 2005. T-cell growth transformation by herpesvirus saimiri is independent of STAT3 activation. J. Virol. 79:5713-5720.
22. Homa, F. L., and J. C. Brown. 1997. Capsid assembly and DNA packaging in herpes simplex virus. Rev. Med. Virol. 7:107-122.
23. Honess, R. W., and B. Roizman. 1974. Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J. Virol. 14:8-19.
24. Jung, J. U., et al. 1991. Identification of transforming genes of subgroup A and C strains of herpesvirus saimiri. Proc. Natl. Acad. Sci. U. S. A. 88:7051-7055.
25. Knappe, A., et al. 1997. The superantigen-homologous viral immediate-early gene ie14/vsag in herpesvirus saimiri-transformed human T cells. J. Virol. 71:9124-9133.
26. Lee, S. I., and J. A. Steitz. 1990. Herpesvirus saimiri U RNAs are expressed and assembled into ribonucleoprotein particles in the absence of other viral genes. J. Virol. 64:3905-3915.
27. Leinbach, S. S., and W. C. Summers. 1980. The structure of herpes simplex virus type 1 DNA as probed by micrococcal nuclease digestion. J. Gen. Virol. 51:45-59.
28. Li, Q., F. Zhou, F. Ye, and S. J. Gao. 2008. Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program. Virology 379:234-244.
29. Lieberman, P. M. 2006. Chromatin regulation of virus infection. Trends Microbiol. 14:132-140.
30. Lu, F., L. Day, S. J. Gao, and P. M. Lieberman. 2006. Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcomaassociated herpesvirus lytic transcription. J. Virol. 80:5273-5282.
31. Lu, F., et al. 2003. Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency. J. Virol. 77:11425-11435.
32. Matsumura, S., Y. Fujita, E. Gomez, N. Tanese, and A. C. Wilson. 2005. Activation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50). J. Virol. 79:8493-8505.
33. Medveczky, P., E. Szomolanyi, R. C. Desrosiers, and C. Mulder. 1984. Classification of herpesvirus saimiri into three groups based on extreme variation in a DNA region required for oncogenicity. J. Virol. 52:938-944.
34. Melendez, L. V., M. D. Daniel, R. D. Hunt, and F. G. Garcia. 1968. An apparently new herpesvirus from primary kidney cultures of the squirrel monkey (Saimiri sciureus). Lab. Anim. Care 18:374-381.
35. Monneret, C. 2005. Histone deacetylase inhibitors. Eur. J. Med. Chem. 40:1-13.
36. Niedermeier, A., et al. 2006. Histone deacetylase inhibitors induce apoptosis with minimal viral reactivation in cells infected with Kaposi's sarcoma-associated herpesvirus. J. Invest. Dermatol. 126:2516-2524.
37. Saemundsen, A. K., B. Kallin, and G. Klein. 1980. Effect of n-butyrate on cellular and viral DNA synthesis in cells latently infected with Epstein-Barr virus. Virology 107:557-561.
38. Schäfer, A., et al. 2003. The latency-associated nuclear antigen homolog of herpesvirus saimiri inhibits lytic virus replication. J. Virol. 77:5911-5925.
39. Shaw, J. E., L. F. Levinger, and C. W. Carter, Jr. 1979. Nucleosomal structure of Epstein-Barr virus DNA in transformed cell lines. J. Virol. 29:657-665.
40. Simmer, B., et al. 1991. Persistence of selectable herpesvirus saimiri in various human haematopoietic and epithelial cell lines. J. Gen. Virol. 72: 1953-1958.
41. Stedman, W., Z. Deng, F. Lu, and P. M. Lieberman. 2004. ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin. J. Virol. 78:12566-12575.
42. Stevenson, A. J., et al. 2000. Specific oncolytic activity of herpesvirus saimiri in pancreatic cancer cells. Br. J. Cancer 83:329-332.
43. Thurau, M., A. Whitehouse, S. Wittmann, D. Meredith, and H. Fickenscher. 2000. Distinct transcriptional and functional properties of the R transactivator gene orf50 of the transforming herpesvirus saimiri strain C488. Virology 268:167-177.
44. Toth, Z., et al. 2010. Epigenetic analysis of KSHV latent and lytic genomes. PLoS Pathog. 6:e1001013.
45. Wang, S. E., et al. 2004. Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway. J. Virol. 78:4248-4267.
46. Wen, K. W., D. P. Dittmer, and B. Damania. 2009. Disruption of LANA in rhesus rhadinovirus generates a highly lytic recombinant virus. J. Virol. 83:9786-9802.
47. Whitehouse, A., A. J. Stevenson, M. Cooper, and D. M. Meredith. 1997. Identification of a cis-acting element within the herpesvirus saimiri ORF 6 promoter that is responsive to the HVS R transactivator. J. Gen. Virol. 78:1411-1415.
48. Williams, B. J., et al. 2005. The prototype gamma-2 herpesvirus nucleocytoplasmic shuttling protein, ORF 57, transports viral RNA through the cellular mRNA export pathway. Biochem. J. 387:295-308.